186 related articles for article (PubMed ID: 32347422)
1. JSH practical guidelines for hematological malignancies, 2018: I. Leukemia-2. Acute promyelocytic leukemia (APL).
Fujita H; Ishikawa Y; Yokoyama Y
Int J Hematol; 2020 Jun; 111(6):747-760. PubMed ID: 32347422
[No Abstract] [Full Text] [Related]
2. [Acute promyelocytic leukemia: state-of-the-art management].
Asou N
Rinsho Ketsueki; 2018; 59(6):725-734. PubMed ID: 29973452
[TBL] [Abstract][Full Text] [Related]
3. [Acute Promyelocytic Leukemia: New treatment strategies with ATRA and ATO - AML-BFM-Recommendations].
Creutzig U; Dworzak M; von Neuhoff N; Rasche M; Reinhardt D
Klin Padiatr; 2018 Oct; 230(6):299-304. PubMed ID: 30399642
[TBL] [Abstract][Full Text] [Related]
4. Acute Promyelocytic Leukemia.
Winkler C
N Engl J Med; 2024 May; 390(17):e42. PubMed ID: 38683728
[No Abstract] [Full Text] [Related]
5. Intravenous arsenic trioxide and all-trans retinoic acid as front-line therapy for low-risk acute promyelocytic leukemia.
Breccia M; Foà R
Expert Rev Hematol; 2019 Feb; 12(2):81-87. PubMed ID: 30572725
[TBL] [Abstract][Full Text] [Related]
6. First report of successful management of acute promyelocytic leukemia in a pregnant female with All-Trans-Retinoic Acid and Arsenic Trioxide-based induction regimen.
Khosla H; Jain A; Tatawadiya S; Prasad P; Nagpal K; Chaudhry S; Sharma M; Gupta DK; Saluja S; Jain A
Blood Cells Mol Dis; 2020 Nov; 85():102476. PubMed ID: 32688220
[No Abstract] [Full Text] [Related]
7. Attenuated arsenic trioxide plus ATRA therapy for newly diagnosed and relapsed APL: long-term follow-up of the AML17 trial.
Russell N; Burnett A; Hills R; Betteridge S; Dennis M; Jovanovic J; Dillon R; Grimwade D;
Blood; 2018 Sep; 132(13):1452-1454. PubMed ID: 30097508
[No Abstract] [Full Text] [Related]
8. [State-of-the-art treatment of acute promyelocytic leukemia].
Kiguchi T
Rinsho Ketsueki; 2018; 59(10):2007-2018. PubMed ID: 30305503
[TBL] [Abstract][Full Text] [Related]
9. [All-trans retinoic acid/arsenic trioxide combination therapy for a patient with acute promyelocytic leukemia on dialysis].
Nagao R; Hosoba R; Yahagi Y; Gunji T; Uryu H; Hattori D; Momoki M; Yamazaki H
Rinsho Ketsueki; 2019; 60(10):1431-1435. PubMed ID: 31695003
[TBL] [Abstract][Full Text] [Related]
10. Arsenic trioxide (trisenox) therapy for acute promyelocytic leukemia in the setting of hematopoietic stem cell transplantation.
Douer D; Hu W; Giralt S; Lill M; DiPersio J
Oncologist; 2003; 8(2):132-40. PubMed ID: 12697938
[TBL] [Abstract][Full Text] [Related]
11. [Successful treatment of acute promyelocytic leukaemia without chemotherapy and blood transfusion].
Tøstesen M; Østgård LSG; Kjeldsen E; Stentoft J; Nørgaard JM
Ugeskr Laeger; 2018 Jan; 180(3):. PubMed ID: 29336300
[TBL] [Abstract][Full Text] [Related]
12. JSH practical guidelines for hematological malignancies, 2023: leukemia-2-acute promyelocytic leukemia (APL).
Fujita H
Int J Hematol; 2024 May; 119(5):481-492. PubMed ID: 38630356
[No Abstract] [Full Text] [Related]
13. JSH guideline for tumors of hematopoietic and lymphoid tissues: leukemia: 2. Acute promyelocytic leukemia (APL).
Asou N; Fujita H; Shinagawa K
Int J Hematol; 2017 Oct; 106(4):459-470. PubMed ID: 28856623
[No Abstract] [Full Text] [Related]
14. Successful Treatment of Acute Promyelocytic Leukemia Complicated with Endometrial Cancer by Arsenic Trioxide.
Sugiura H; Nishimori H; Matsuoka H; Nakamura K; Fujii K; Fujii N; Matsuoka KI; Maeda Y
Acta Med Okayama; 2021 Apr; 75(2):219-224. PubMed ID: 33953429
[TBL] [Abstract][Full Text] [Related]
15. Management of acute promyelocytic leukemia.
Tallman MS; Nabhan C
Curr Oncol Rep; 2002 Sep; 4(5):381-9. PubMed ID: 12162911
[TBL] [Abstract][Full Text] [Related]
16. CPSF6-RARG-positive acute myeloid leukaemia resembles acute promyelocytic leukaemia but is insensitive to retinoic acid and arsenic trioxide.
Li J; Yan WZ; Bai LH; Jiang YF; Peng HL; Shen JK; Li RJ
Pathology; 2023 Apr; 55(3):407-412. PubMed ID: 36241556
[No Abstract] [Full Text] [Related]
17. Successful treatment of acute promyelocytic leukemia in pregnancy with single-agent all-trans retinoic acid.
Nellessen CM; Janzen V; Mayer K; Giovannini G; Gembruch U; Brossart P; Merz WM
Arch Gynecol Obstet; 2018 Feb; 297(2):281-284. PubMed ID: 29110117
[TBL] [Abstract][Full Text] [Related]
18. Real world data with concurrent retinoic acid and arsenic trioxide for the treatment of acute promyelocytic leukemia.
Kulkarni UP; Selvarajan S; Lionel S; Prakash MA; Palani HK; Balasundaram N; Venkataraman A; Korula A; Devasia AJ; Fouzia NA; Janet NB; Nair SC; Abraham A; Mani T; Lakshmanan J; Arunachalam AK; Balasubramanian P; George B; Mathews V
Blood Cancer J; 2022 Jan; 12(1):22. PubMed ID: 35102152
[No Abstract] [Full Text] [Related]
19. Towards Optimizing Risk-adapted Treatment of APML in ATRA/ATO Era: How Can Prediction of Early Mortality Help?
Buhtoiarov IN
J Pediatr Hematol Oncol; 2021 May; 43(4):158. PubMed ID: 33625082
[No Abstract] [Full Text] [Related]
20. Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet.
Sanz MA; Fenaux P; Tallman MS; Estey EH; Löwenberg B; Naoe T; Lengfelder E; Döhner H; Burnett AK; Chen SJ; Mathews V; Iland H; Rego E; Kantarjian H; Adès L; Avvisati G; Montesinos P; Platzbecker U; Ravandi F; Russell NH; Lo-Coco F
Blood; 2019 Apr; 133(15):1630-1643. PubMed ID: 30803991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
